AI transforms
industry
AI is changing how industries analyze, predict and create.
Quantum Intelligence Corp.
Beyond Artificial Intelligence.
Into Quantum Intelligence.
By uniting artificial intelligence with quantum computing, QIC is building a new industrial paradigm for addressing complex challenges that will shape the future.
01 / Why Quantum–AI
AI is transforming industry. Quantum–AI expands what technology can solve.
AI is reshaping every industry, but important problems remain beyond what AI alone can effectively address. By combining AI with quantum computing, Quantum–AI hybrid technology opens new possibilities for solving complex industrial challenges. QIC is building this technology and applying it where it can create meaningful value.
AI transforms
Some problems
remain beyond AI
High-value industrial challenges can exceed the limits of AI and conventional computing alone.
Quantum–AI
extends the frontier
QIC combines both technologies to address complex problems with a new level of capability.
02 / Core Technology
Quantum and AI, designed to work together.
Quantum AI combines the learning and predictive capabilities of artificial intelligence with the computational potential of quantum technologies. QIC identifies where each technology can create the greatest value and integrates them into hybrid systems designed for complex, real-world industry problems.
Making quantum
more practical
AI supports the control, optimization and practical use of quantum systems.
Extending what AI
can address
Quantum methods extend selected simulation, search and optimization capabilities within AI-driven systems.
Knowing where and
how to combine them
QIC determines where quantum methods can add value and integrates them with AI, conventional computing and domain expertise.
QIC’s core capability lies in matching the right industry problem with the right combination of AI, quantum methods and domain validation.
Explore Our Technology →03 / Business Portfolio
Quantum–AI solutions for high-value industries—and proprietary assets built with them.
QIC focuses on drug discovery and finance—two fields where complex scientific and computational challenges create significant opportunities for Quantum–AI. Our solutions combine advanced technology with domain expertise to address critical industry bottlenecks, improve efficiency and support better outcomes. In drug discovery, QIC also uses its own platform to build a proprietary pipeline, creating an additional asset-based business model while demonstrating the platform’s value through real development programs.
QIC BUSINESS PORTFOLIOTwo Quantum–AI solution businesses and one proprietary asset business
SOLUTION BUSINESS · 01–02
Quantum–AI
Drug Discovery
An integrated Quantum–AI drug-discovery platform supporting AI-based hit discovery, molecular structure and interaction analysis, lead optimization, candidate evaluation, and preclinical ADMET/PK prediction.
- Hit discovery and candidate prioritization
- Molecular structure and interaction analysis
- Lead optimization and candidate evaluation
- Preclinical ADMET/PK prediction · Virtual CRO
Quantum–AI
Financial Intelligence
A Quantum–AI financial intelligence platform designed to address complex prediction, evaluation and optimization problems involving large combinations of variables, rules and operational constraints.
- Credit evaluation and predictive intelligence
- Ruleset and portfolio optimization
- Anomaly detection and decision support
- Industry PoC and operational validation
PROPRIETARY ASSET BUSINESS · 03
03PROPRIETARY ASSET BUSINESSQIC DRUG PIPELINEBuilt with QUEST™5-Program
5-Program
Drug Portfolio
QUEST™ also creates proprietary drug assets. QIC develops these programs through internal research and partnerships, building a business pathway through co-development and licensing.
Explore Our 5-Program Pipeline →04 / Proprietary Drug Pipeline
A targeted-therapy portfolio built for multiple value-creation paths.
Five programs across RPT, PDC and oral peptides. Explore each target, indication and current development stage below.
TargetIndicationModalityStage
CA IXClear-cell renal cell carcinomaRPTPreclinicalGLP preparation
CA XIIRecurrent ovarian cancer · TNBCPDCLead Optimization
MC1RMetastatic melanoma · 2L+RPTLead Optimization
FAPPan-cancer solid tumorsPancreatic cancer · CRC · SarcomaRPTLead Optimization
Integrin α4β7Inflammatory bowel diseaseJoint development with D&D PharmatechOral PeptideORALINK-enabledLead Optimization
05 / Strategic Partnerships
Building the Quantum–AI ecosystem with world-class technology and research partners.
QIC works with leading quantum technology companies, academic research institutions and domain partners to connect advanced computing with real industrial problems. These strategic relationships provide access to quantum platforms, scientific expertise, experimental validation and industry data across drug discovery and finance.
IBM Quantum
OQC
QuEra
Pasqal
Quandela
Classiq
SNU Hybrid Quantum Computing Center
Yonsei Quantum Computing Center
UNIST
University of Minnesota
Korea Institute of Toxicology
WuXi AppTec
Kyungdong Pharm
D&D Pharmatech
Biotoxtech
SNU College of Medicine
KAIST
Sungkyunkwan University
NICE Information Service
Singapore Management University06 / News & Updates
Research, partnerships and progress from QIC.
Follow QIC’s latest research achievements, technology collaborations, business milestones and media coverage.
07 / Contact & Collaboration
The next breakthrough will be built together.
QIC collaborates with technology companies, research institutions, industry leaders and exceptional talent to transform Quantum–AI from scientific possibility into measurable industrial value. Connect with us to explore joint research, technology validation, business collaboration, investment and career opportunities.
START A CONVERSATIONinfo@qic.ai ↗
Research & TechnologyJoint research · Quantum–AI collaboration · Industry PoCResearch inquiry →
Business & LicensingQUEST™ · FintelliQ™ · Drug co-development · Pipeline licensingBusiness & licensing inquiry →
Investment & CorporateStrategic investment · IR · Corporate and media inquiriesIR inquiry →
Careers & TalentJoin a multidisciplinary team advancing Quantum–AI across science and industry.Explore Careers →